$37.48
-0.16-0.43%
Last update: 11:08 AM
15 minutes delayed
ALPS Medical Breakthroughs ETF (ARCA: SBIO)
Ticker | Name | Share % | |
---|---|---|---|
PCVX | Vaxcyte Inc | 5.18% | |
CERE | Cerevel Therapeutics Holdings Inc. | 5.04% | |
VKTX | Viking Therapeutics Inc Com | 4.45% | |
RVMD | Revolution Medicines Inc Ser C Pc Pp | 4.30% | |
SMMT | Summit Therapeutics Plc Spon Adr | 4.14% | |
IE | Alkermes Plc | 2.67% | |
AXSM | Axsome Therapeutics, Inc. | 2.37% | |
CRNX | Crinetics Pharmaceuticals Inc Com | 2.36% | |
CORT | Corcept Therapeutics Inc | 2.13% | |
MRUS | Merus Nv | 2.10% |
The SBIO ETF is currently trading at $37.48, which represents a -0.43% change. Over the past 52 weeks, the ETF has traded as high as $38.80 and as low as $23.21.
The expense ratio of SBIO is 0.5%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for SBIO is 115.14M. This represents the total market value of the assets managed by the ETF.
SBIO follows a Small Cap Growth investment style.
The top holdings of SBIO include: PCVX (5.18%), CERE (5.04%), VKTX (4.45%), RVMD (4.30%), SMMT (4.14%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for SBIO is currently not available.